The Search for a New Marker of Renal Function in Older Patients with Chronic Kidney Disease Stages 3-4: Usefulness of Cystatin C-Based Equations

被引:7
作者
Fontsere, Nestor [1 ]
Esteve, Vicens [5 ]
Saurina, Ana [5 ]
Pou, Monica [5 ]
Barba, Nuria [6 ]
Deulofeu, Ramon [2 ]
Di Gregorio, Silvana [3 ]
Miguel del Rio, Luis [3 ]
Rios, Jose [4 ]
Torres, Ferran [4 ]
Maduell, Franscesc [1 ]
Campistol, Josep M. [1 ]
Ramirez de Arellano, Manel [5 ]
机构
[1] Hosp Clin Barcelona, Dept Nephrol, ES-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Lab Med, ES-08036 Barcelona, Spain
[3] Univ Autonoma Barcelona, Cetir Grp Med Barcelona, E-08193 Barcelona, Spain
[4] Univ Autonoma Barcelona, Epidemiol & Biostat Lab, E-08193 Barcelona, Spain
[5] Consorci Sanitari Terrassa, Dept Nephrol, Barcelona, Spain
[6] Consorci Sanitari Terrassa, Dept Lab Med, Barcelona, Spain
来源
NEPHRON CLINICAL PRACTICE | 2009年 / 112卷 / 03期
关键词
Advanced age; Chronic kidney disease stages 3-4; Cystatin C; Conventional prediction equations; Glomerular filtration rate; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; PREDICTION; MORTALITY; MASS;
D O I
10.1159/000214212
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim: Cystatin C (Cys C) is an endogenous marker of glomerular filtration rate (GFR) unaffected by body composition. The aim of the present study was to assess the utility of Cys C-based GFR prediction equations (Hoek, Larsson and Stevens) and creatinine (modification of diet in renal disease-isotope dilution mass spectrometry - MDRD-IDMS, and Cockcroft-Gault - CG) compared with Cr-51-EDTA. Methods: This study was carried out in 40 Caucasian older patients with advanced age (>= 60) and chronic kidney disease stages 3-4. To assess the utility of prediction equations in relation to body composition, we measured lean mass (LM) with densitometry (DXA). Pearson's, Bland-Altman and Lin's coefficient (Rc) were used to study accuracy and precision. Results: Cr-51-EDTA was 36.9 +/- 9.2 ml/min/1.73 m(2) (22-60). Cys C levels were 2.2 +/- 0.8 mg/l (r = 0.085; p = 0.662 LM) and creatinine 2.8 +/- 1.1 mg/dl (r = 0.427; p = 0.021 LM). The most accurate equations were the Hoek, Larsson and Stevens formulae, with a bias of -0.2 (Rc 0.48), -2.9 (Rc 0.44) and 2.6 ml/min/1.73 m(2) (Rc 0.58). The biases obtained with MDRD-IDMS and CG were -14.6 (Rc 0.35) and -12.5 (Rc 0.40). All correlations among biases obtained with creatinine-based formulae and LM were negative and statistically significant (p < 0.05). Conclusions: The results show superiority of Cys C-based GFR formulae over the MDRD-IDMS and CG equations. This significant underestimation obtained with conventional prediction equations was directly related to the influence of LM. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:C164 / C170
页数:7
相关论文
共 45 条
  • [41] Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease
    Malyszko, Jolanta
    Bachorzewska-Gajewska, Hanna
    Sitniewska, Ewa
    Malyszko, Jacek S.
    Poniatowski, Boguslaw
    Dobrzycki, Slawomir
    RENAL FAILURE, 2008, 30 (06) : 625 - 628
  • [42] Comparison of cystatin C and creatinine-based estimated glomerular filtration rate equations among elderly chronic kidney disease patients attending a tertiary care hospital: A prospective cross-sectional study
    Khan, Irfanullah
    Khan, Amer Hayat
    Adnan, Azreen Syazril
    Naqvi, Atta Abbas
    Rehman, Anees Ur
    Ahmad, Nafees
    Ishaqui, Azfar Athar
    Bitar, Ahmad Naoras
    CLINICAL NEPHROLOGY, 2020, 93 (05) : 217 - 226
  • [43] Impact of Serum Creatinine-- and Cystatin C- Based Sarcopenia Index on Renal Outcomes in Non- Dialysis-Dependent Chronic Kidney Disease Patients: Results From the KNOW-CKD Study
    Kang, Donghyuk
    Lee, Kyu-Beck
    Yoo, Tae-Hyun
    Kim, Soo Wan
    Oh, Kook-Hwan
    Kim, Yaeni
    MAYO CLINIC PROCEEDINGS, 2024, 99 (09) : 1388 - 1398
  • [44] Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin
    Hasslacher, Christoph
    Kulozik, Felix
    JOURNAL OF DIABETES, 2016, 8 (05) : 712 - 719
  • [45] Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes
    Miyoshi, Hideaki
    Kameda, Hiraku
    Yamashita, Kumiko
    Nakamura, Akinobu
    Kurihara, Yoshio
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) : 1510 - 1517